Out-of-date browser detected
Your browser appears to be out-of-date, and portions of the site may not function as intended.
Please install a current version of Chrome, Firefox, Edge, or Safari for a better experience.
Purpose
to develop, manufacture, and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Wildcat MDx platform for limited resource settings.
Grantee
Division
Global Health
Year Awarded
2012
Region Served
GLOBAL
Committed Amount
$20,912,487
Grant Topic
HIV
Duration (Months)
62
Grantee Location
San Diego, California, United States
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.